药石科技(300725) - 2021 Q3 - 季度财报

Revenue and Profit - Revenue for Q3 2021 reached ¥281,580,503.73, an increase of 5.86% year-over-year, and year-to-date revenue was ¥902,929,920.72, up 24.47% compared to the same period last year[3] - Net profit attributable to shareholders for Q3 2021 was ¥61,139,845.82, reflecting an 11.16% increase year-over-year, while year-to-date net profit reached ¥442,378,059.29, a significant increase of 210.79%[3] - Basic earnings per share for Q3 2021 was ¥0.3096, up 6.06% year-over-year, and year-to-date basic earnings per share was ¥2.2399, an increase of 196.48%[3] - The net profit for the current period reached ¥451,168,056.54, a significant increase from ¥142,336,400.41 in the previous period, representing a growth of approximately 216%[31] - Operating profit rose to ¥463,997,310.40, compared to ¥159,791,605.86 in the previous period, indicating an increase of approximately 190%[31] - The total comprehensive income attributable to the parent company was ¥441,969,413.36, compared to ¥143,729,861.27 in the previous period, reflecting a growth of approximately 208%[34] Assets and Liabilities - Total assets as of September 30, 2021, amounted to ¥3,425,895,867.08, representing a 41.26% increase from the end of the previous year[3] - Total assets rose to ¥3,425,895,867.08, compared to ¥2,425,289,638.00, reflecting a growth of 41.3%[27] - Total liabilities increased to ¥884,670,164.68 from ¥530,568,842.44, a rise of 66.6%[27] - The company’s total liabilities increased significantly, with other payables rising by 144.25% to ¥170,581,634.56, mainly due to unpaid equity acquisition payments related to the Zhejiang Huishi acquisition[9] Cash Flow - The company’s cash flow from operating activities for the year-to-date was ¥280,486,246.32, reflecting a 63.37% increase compared to the same period last year[3] - Cash flow from operating activities netted ¥280,486,246.32, compared to ¥171,684,225.08 in the previous period, showing an increase of approximately 63%[35] - Cash received from investment activities increased by 334.82% to ¥2,081,124,500.00, driven by the purchase and redemption of financial products[9] - Investment activities generated a net cash flow of -¥693,221,828.81, compared to -¥17,822,647.70 in the previous period, indicating a significant increase in investment outflows[35] - Cash inflow from financing activities totaled $180,273,159.65, compared to $135,504,460.00 in the previous period, representing an increase of approximately 33%[41] - Net cash flow from financing activities was $40,005,468.30, down from $50,815,576.69, indicating a decrease of about 21%[41] - The ending balance of cash and cash equivalents was $866,160,060.83, compared to $340,432,092.04 in the prior period, showing a significant increase of approximately 154%[41] Investments and Acquisitions - The company reported a significant increase in goodwill to ¥356,185,571.87, a rise of 1041.50% due to the acquisition of Zhejiang Huishi[6] - The company’s long-term equity investments decreased by 94.48% to ¥8,599,762.10, primarily due to the acquisition of Zhejiang Huishi[6] - The company’s fixed assets increased by 310.83% to ¥567,408,211.24, attributed to the consolidation of Zhejiang Huishi[6] - Long-term deferred expenses increased by 208.99% to ¥7,253,341.03, primarily due to the acquisition of Zhejiang Huishi[9] - Other non-current assets rose by 728.67% to ¥55,580,283.44, mainly from increased prepayments for engineering and equipment[9] - Investment income surged by 6408.07% to ¥234,095,468.64, attributed to the revaluation of a 37.43% equity stake in Zhejiang Huishi acquired during the reporting period[9] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 16,291[13] - The largest shareholder, Yang Minmin, holds 20.68% of the shares, amounting to 41,307,019 shares[13] - The total number of restricted shares at the end of the period was 36,910,154, an increase from 28,302,372 at the beginning of the period[17] - The company plans to unlock 25% of restricted shares annually based on the previous year's holdings for executives[17] Expenses and Taxation - Total operating costs amounted to ¥671,997,967.05, up 18.4% from ¥568,120,590.43 in the previous period[28] - The company reported a 71.88% increase in taxes paid, totaling ¥39,321,299.94, due to higher income tax payments[9] - The company reported a tax expense of ¥21,884,710.21, down from ¥24,587,183.84, indicating a decrease of approximately 11%[31] Research and Development - Research and development expenses grew by 41.48% to ¥81,457,397.06, as the company continues to invest in technological innovation[9] - Research and development expenses increased to ¥81,457,397.06 from ¥57,574,920.12, marking a rise of about 42%[31] Other Financial Information - The company did not apply the new leasing standards for the first time in 2021, indicating no adjustments to prior financial statements[42] - The third quarter report was not audited, which may affect the reliability of the financial data presented[42]